MGRX vs NWL · rev $456.0K vs rev $3.54B
Mangoceuticals, Inc. Common Stock (MGRX) versus Newell Brands Inc (NWL) — a side-by-side from cached financials, not a winner call.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Newell Brands Inc (NWL) is a household & personal products company listed on NASDAQ.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
Latest reported NWL revenue for 2026-06-30 was $3.54B. Net income was $73.0M. NWL currently screens at market cap $2.11B.
MGRX currently screens at market cap $16.3M. NWL currently screens at market cap $2.11B.
Not investment advice. Open the MGRX and NWL stock pages for the full models.
Not investment advice.